Navigation Links
Smoking Ban Lights Up Smoking-Cessation Initiatives

Smoke line, a national ant-smoking hotline, managed by the NHS Heath Scotland, has had its lines choked with the increased influx of phone calls, following the smoking ban in Scotland since Sunday, last. // The line which normally receives about 100 calls a day, registered a four fold increase of almost 450 calls a day, post ban

Other Anti smoking help lines equally faced an increased flow of calls. This is a shot in the arm for the anti-smoking drive, and campaigners believe, the ban will certainly bring down the number of smokers in England.

An NHS Spokeswoman said “We are absolutely delighted in the increased interest this week. It follows a successful year for Smoke line in which we have expanded our support services in response to growing demand."

Maureen Moore, chief executive of the anti-smoking group ASH Scotland, said: "It's great to hear about the rise in calls to Smoke line and we're delighted that people are using the ban as motivation to quit smoking. Getting specialist help like this really increases your chances of success, too. Seventy per cent of Scots smokers say they would like to stop, and smoke-free public places will support them to quit by removing the cues that often make people relapse."


'"/>




Page: 1

Related medicine news :

1. New hope on the Horizon for People Wishing to Quit Smoking
2. Cancers of Colon & Rectum linked to Cigarette Smoking
3. Smoking a greater risk than HIV? Yes say health experts!!!!
4. Kick Smoking with Nicotine Drink
5. Smoking spreads Cancer
6. Prescription Drug - Helps People Stop Smoking
7. Quit Smoking
8. Smoking can depreciate intellegence
9. Smoking Delays Pregnancy
10. Smoking Linked To Low Infant Birth Weight
11. GlaxoSmithKline To Cultivate Non-Smoking Environment

Post Your Comments:
(Date:12/2/2009)...atches now available, many more to come, NIH direc...Day News) -- Thirteen stem cell lines have been a...yer-funded research, and many more such lines will...ounced Wednesday. , These are the first additio...h funded by the U.S. National Institutes of Health...
(Date:12/2/2009)... SAN FRANCISCO, Dec. 2 ...bies are born contaminated with a plastics chemica...ess must act immediately to protect infants and mo...bills to ban bisphenol A, or BPA, in food and beve...in of California and Rep. Edward Markey of Massach...
(Date:12/2/2009)..., MONTREAL, Dec. 2 /PRNewswire/ - As part of its c...world, Wyeth, now a part of Pfizer, has pledged mo...ctor concentrates to the World Federation of Hemop...e to the WFH,s Humanitarian Aid Program, and will ...ls. ,, "This donation will directly support bui...
(Date:12/2/2009)... , Ruling by federal government ends nine ... ANGELES, Dec. 2 More t...iser Permanente facilities across Southern Califor... National Union of Healthcare Workers (NUHW). ,...n NUHW in February, but SEIU delayed the election ...
(Date:12/2/2009)... MAJoseph Balboni loves sports. An avid tennis pla...ar-old insurance agent became increasingly frustra...conus, a degenerative eye disorder. Unable to retu...es, he faced the prospect of a corneal transplant ...ree years ago, Balboni discovered an alternative t...
Breaking Medicine News(10 mins):Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA 2Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2Health News:Brandeis studies evaluate visionary approach to improving eyesight 2
...aid that older hospital patients with delirium run...e condition. Researchers suggested there's a need ...nt can be made and to investigate interventions th...onal delirium - described as possible hallucinatio...
... may be only a dash and sprinkel away: Researchers...d that herbs, in addition to making food tastier, ...rovide potential anticancer benefits when suppleme...dings appear in the Journal of Agricultural and Fo...
...a recent study a device was found using new techno... of screening people for potential stroke involves...arotid arteries that serve the brain.// Resear...e, this was used to take two different images in a...
...hat protects children against measles, mumps and r... growing list of scarce drugs, with shortfalls cau... pharmaceutical companies choosing to stop making ...neumococcal vaccine used to prevent bacterial meni...
...s are confirming in laboratory studies that one of...ted from beehives--may inhibit the development of ...inas, Brazil, found that propolis// considerably r...promote the binding of cariogenic bacteria to teet...
...now say that a region in the brain responsible for...pathise for others and help the needy. Neuroscient... brain regions involved in learning by imitation./...inguish the self from others.The research, done by...
Other Medicine News:Health News:Herbs: rich soure of antioxidants 2Health News:The brain wave 2
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewsw...e" or the "Company") (NYSE: SCR ), a leading pha...t, manufacturing, and marketing of branded,generic...eported that its,subsidiary Jiangsu Yanshen Biolog...) has suspended production of all its products in ...
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PRN..., including a late-breaking presentation on Tasign...hronic myeloid leukemia, demonstrate the strength ... the care of patients. ,, The new data, at the...Meeting and Exposition, highlight the company,s cu...
(Date:12/1/2009)..., , TEMECULA, Calif., Dec. 1 /PRNewswire-Fi... Bulletin Board: PSTX) announced today that it has...of Chief Financial Officer, Treasurer and Corporat...cting CFO since 2008. Prior to joining Patient Sa...nt Finance, Chief Financial Officer, Treasurer and...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Humans Can Develop Bat Like Echolocation 51093 1Humans Can Develop Bat Like Echolocation 51093 2Communicating science to decision makers 51089 1Omega 3s Benefit Heart Attack Survivors Healthy Adults Mothers and Infants 51086 1Omega 3s Benefit Heart Attack Survivors Healthy Adults Mothers and Infants 51086 2
...SS WIRE)--Jun 5, 2007 - Javelin,Pharmaceuticals, I...ucts for pain control, today announced that its Ph...n Pain Medicine, the,official journal of The Ameri...d, "Analgesic Efficacy and Safety of,Morphine-Chit...evere Pain Following Orthopedic Surgery", was rece...
...ta Presented at the , 2007 American Society of Cli...) Activity in Older Patients with AML and in,Refra...on of the molecular interaction of Aloxi(R),with ,...rvival Analysis of Glioblastoma Patients,Treated ,...cribed-- , --Survival Analysis of Irofulven in Sec...
Other Medicine Technology:Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine),Data Published in Pain Medicine 2Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine),Data Published in Pain Medicine 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10
Right Dr. White Carina Hook
SHERIDAN LASER-TRACH Endotracheal Tubes
SHERIDAN LAR-A-JECT® Reinforced Laryngectomy Tubes
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes
Medicine Products: